Glenmark gets USFDA nod for generic skin inflammation treatment foam
Glenmark's skin foam gets USFDA nod Glenmark Pharmaceuticals on Monday said it has received final approval from the US health regulator for its gener18-02-2019
18-02-2019
Glenmark Pharmaceuticals Ltd - 532296 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Glenmark Pharmaceuticals receives ANDA approval for Clobetasol Propionate Foam, 0.05%18-02-2019
GLENMARK PHARMACEUTICALS LTD. - 532296 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Glenmark Pharmaceuticals receives ANDA approval for Clobetasol Propionate Foam, 0.05%18-02-2019
Glenmark to spin off innovation business into a new company in the US
Drugmaker Glenmark Pharmaceuticals Ltd has decided to spin off its innovation business into a new company in the United States, a move that will get14-02-2019
Glenmark Pharmaceuticals Ltd - 532296 - Unaudited Financial Results For The Third Quarter And Nine Months Ended December 31, 2018
Sub: Outcome of the Board Meeting - February 14, 2019 Ref.: Intimation under Regulations 30 and 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('LODR, 2015') Pursuant to Regulations 30 and 33 of the SEBI LODR, 2015, we wish to inform you that Board has today at its meeting approved the Unaudited Financial Results for the Third Quarter and Nine Months ended December 31, 2018. The said meeting of the Board commenced at 2.00 p.m. and concluded at 4.44 p.m. The copy of the said results together with Management Discussion & Analysis, Press Release and Limited Review Report of the Auditors is enclosed herewith. These are also being made available on the website of the Company at www.glenmarkpharma.com.14-02-2019
Glenmark Pharmaceuticals Ltd - 532296 - Outcome of Board Meeting
Sub: Outcome of the Board Meeting - February 14, 2019 We wish to inform you that Board at its meeting held today has given an in-principle approval to spin off the innovation business into a new company in the US. Kindly find the attached media release regarding the same, which is self-explanatory.14-02-2019
Glenmark Pharma gets USFDA nod for dialysis treatment drug
Glenmark Pharmaceuticals on Monday said it has received final approval from the US health regulator for Sevelamer Hydrochloride tablets, used to contr11-02-2019
Glenmark Pharmaceuticals Ltd - 532296 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Sub: Glenmark Pharmaceuticals receives ANDA approval for Sevelamer Hydrochloride Tablets, 400 mg and 800 mg11-02-2019
Glenmark gets tentative USFDA nod for generic advanced breast cancer injection
Drug firm Glenmark Pharmaceuticals Thursday said it has received tentative approval from the US health regulator for generic Fulvestrant injection us07-02-2019
Glenmark Pharmaceuticals Ltd - 532296 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Glenmark Pharmaceuticals receives tentative ANDA approval for Fulvestrant Injection, 250 mg/5 mL (50 mg/mL)07-02-2019